Skip to content

Henry Schein

US · HSIC #1526 by market cap Listed 1970
83.52 -1.28 -1.51%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 23 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.7 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
113.78% -0.74pp
Institutions
698 +23
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund77.30%
VC/PE Fund14.83%
Hedge Fund11.28%
Public Company4.05%
Private Company3.51%
Individual/Insider1.20%
Sovereign Wealth Fund1.13%
Government Pension Fund0.98%
Insurance Company0.45%

Top holders as of 2026-06-30

KKR & Co. Inc. 14.16% · 15.65M sh
BlackRock 6.38% · 7.06M sh
FMR 6.29% · 6.95M sh
Vanguard Capital Management, LLC 5.66% · 6.25M sh
Artisan Partners Limited Partnership 4.98% · 5.51M sh
State Street Global Advisors 3.89% · 4.30M sh
Vanguard Portfolio Management, LLC 3.68% · 4.07M sh
J.P. Morgan Asset Management, Inc. 3.41% · 3.77M sh
Dimensional Fund Advisors 3.19% · 3.52M sh
American Century Investment Management 3.10% · 3.46M sh
Southpoint Capital Advisors LP 2.99% · 3.30M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 22 sells

NameRoleStake
KKR & Co. Inc. -- 14.16%
Stanley Bergman Former Chairperson 0.58%
James Breslawski Former President 0.14%
Andrea Albertini Chief Executive Officer of Global Distribution & Technology 0.11%
Tom Popeck Chief Executive Officer of Henry Schein Products Group 0.08%
Bradford Connett Former President of U.S. Medical Group 0.06%
Walter Siegel Former Senior VP & Chief Legal Officer 0.04%
Carol Raphael Former Independent Director 0.03%
Joseph Herring Former Independent Director 0.03%
Michael Ettinger Former Chief Operating Officer 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-07 Andrea Albertini Chief Executive Officer of Global Distribution & Technology Sale to Issuer -4,587 $88.86
2026-06-29 Joseph Herring Former Independent Director Intent to Sell (Form 144) -28,791 $84.29
2026-06-11 William Daniel Independent Chairperson Other Acquisition +2,215 --
2026-05-25 Stanley Bergman Former Chairperson Other Disposition -50 --
2026-05-20 Kelly Murphy General Counsel Initial Statement of Beneficial 0 --
2026-05-18 Stanley Bergman Former Chairperson Other Disposition -1,040 --
2026-05-10 William Daniel Independent Chairperson Open Market Acquisition +10,000 $69.19
2026-03-18 Tom Popeck Chief Executive Officer of Henry Schein Products Group Open Market Disposition -1,355 $72.79
2026-03-16 Michael Ettinger Former Chief Operating Officer Other Disposition -2,300 --
2026-03-15 Stanley Bergman Former Chairperson Sale to Issuer -50 $74.61
2026-03-15 Stanley Bergman Former Chairperson Other Disposition -400 --
2026-03-15 Mark Mlotek Former Executive VP & Chief Strategic Officer Sale to Issuer -5,928 $74.61
2026-03-15 Michael Ettinger Former Chief Operating Officer Sale to Issuer -4,214 $74.61
2026-03-15 Ronald South Former Senior Vice President Sale to Issuer -5,216 $74.61
2026-03-15 Andrea Albertini Chief Executive Officer of Global Distribution & Technology Sale to Issuer -1,401 $74.61
2026-03-15 Tom Popeck Chief Executive Officer of Henry Schein Products Group Sale to Issuer -587 $74.61
2026-03-15 Christine Sheehy Chief Human Resources Officer Sale to Issuer -463 $74.61
2026-03-11 Stanley Bergman Former Chairperson Other Disposition -970 --
2026-03-09 Kurt Kuehn Independent Director Open Market Disposition -2,844 $78.96
2026-03-05 Henry Kravis -- Other Derivative Acquisition +918,723 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:01:08 · For reference only, not investment advice and not tailored to your situation.

Henry Schein discussion 0 comments

Add a comment